Skip to content
CytoTrack logo — Discover the Future of Tumor Cell Detection with Unparallele...

CytoTrack

Discover the Future of Tumor Cell Detection with Unparalleled Precision and Speed

Founded 2004 Grant Total: $50.00K Biotechnology, Health Care +1

General Information

Company Name CytoTrack
Founded Year 2004
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with CytoTrack. To contact CytoTrack, visit cytotrack.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CytoTrack compare?

A PDF of CytoTrack and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CytoTrack soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CytoTrack

CytoTrack is a biotechnology startup with a focus on revolutionizing tumor cell detection through its advanced medical technology platform. The company's slogan, "Discover the Future of Tumor Cell Detection with Unparalleled Precision and Speed," encapsulates its commitment to innovation. CytoTrack's technology is designed to detect Circulating Tumor Cells (CTCs) in blood with unique capabilities, distinguishing itself by its ability to identify CTCs without relying on EpCAM enrichment or size-based filtration.

The standout feature of CytoTrack's platform is its exceptional scanning capacity, boasting the ability to scan 100 million cells per minute. Moreover, the CytoPicker feature allows for the isolation of single intact cells for downstream applications such as Single Cell PCR and FISH.

Initially developed as part of a research initiative at The National Hospital of Denmark and led by Professor John Philip, the technology was originally aimed at identifying FCMB (Foetal Cells in Maternal Blood). This project highlighted the inadequacy of conventional instruments such as flow cytometry and common fluorescent scanners in detecting rare fetal cells and their lack of molecular characterization capabilities.

Christian Caspersen created the CytoTrack technology to address the challenges of rare cell detection, and it has since been adapted for various applications, including the detection of CTCs. The startup was founded in 2004 and received a €50.00K grant investment on 10 January 2015 from EASME - EU Executive Agency for SMEs.

Business keywords: tumor cell detection, blood analysis, rare cell detection, CTC detection, cell isolation, single cell analysis, PCR, FISH, research initiative, high scanning capacity, molecular characterization, cytotechnology, biomedical innovation, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
10 Jan 2015

CytoTrack Alternatives & Competitors

View All Alternatives
CytoTrack vs
Capio Biosciences
Capio Biosciences United States

Our Vision: To be the world’s leading liquid biopsy company providing valuable clinical information...

Series A
4 employees
Biotechnology, Health Care
CytoTrack vs

Advancing diagnostic procedures for precision medicine

Acquired
8 employees
Biotechnology, Health Care
CytoTrack vs
Sampling Human
Sampling Human United States

Single cell analysis at massive scale.

Seed
14 employees
Big Data, Biotechnology

FAQ About CytoTrack

Discover the Future of Tumor Cell Detection with Unparalleled Precision and Speed
CytoTrack was founded in 2004.
CytoTrack operates in Biotechnology, Health Care and Medical Devices. Its work centres on tumor cell detection, blood analysis, rare cell detection and CTC detection.
CytoTrack has completed 1 funding round, raising a total of $50.00K. The latest funding stage is Grant.
Top alternatives and competitors to CytoTrack include Capio Biosciences, GILUPI GmbH, Sampling Human, Celldom, Inc., Ikonisys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CytoTrack and Capio Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CytoTrack, https://bouncewatch.com/company/cytotrack, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout